INSIGHTS ON DRUG DEVELOPMENT
-
Advancing Cell Therapies With Lipid Nanoparticles
Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.
-
What Is A Viral Vector?
Review a novel adenovirus production process that offers scalable, single-use equipment-compatible solutions, reducing production time and cross-contamination risks.
-
Revolutionizing Viral Infectious Disease Research And Drug Discovery
Learn how Organ-Chips are being used to rapidly identify promising treatments, investigate virus evolution, and analyze how mechanical forces influence the innate immune response to viral infections.
-
mTOR Pathway
Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.
-
Evaluating CAR T-Cell Therapy Vascular Recruitment, Trafficking, And Killing4/24/2024
Learn about a more human-relevant platform that enables researchers to assess the trafficking and killing efficiency of immunotherapy as well as the proof-of-concept of immuno-oncology co-therapy.
-
How Recent Trends Impact Bringing Your Molecule To Market7/9/2024
With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.
-
Customer Spotlight: Queen Mary University Of London's Centre For Predictive In Vitro Models5/10/2024
Discover the future of in vitro modeling at the Queen Mary+Emulate Organs-on-Chips Centre and unlock new possibilities in the field of predictive medicine.
-
How Lipid Nanoparticles Enable Next-Gen Delivery10/20/2025
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
Comprehensive GMP Testing Services3/31/2025
Eurofins delivers global GMP testing with 45+ facilities, ensuring regulatory acceptance, quality, and trusted service from starting materials to finished products.
DRUG DEVELOPMENT SOLUTIONS
-
We have developed an innovative portfolio of affinity chromatography resins to help you solve challenges in the downstream process of next-generation antibody therapeutics. These resins are specifically designed for the purification of engineered monoclonal antibody (mAbs) modalities.
-
Easily analyze a diverse array of RNA species, from 50-9,000 bases, and achieve high-resolution data with a purity & integrity kit.
-
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
Integrate an automated cell imaging system with high-resolution imaging and robust analytics into your processes to streamline workflows for fluorescence and brightfield assays.
-
Measure heat flow, weight loss, dimension change, or mechanical properties as a function of temperature.